Skip to content

AptarGroup ATR Total costs & expenses

Total costs & expenses at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$192.19M+55.8%
United Therapeutics logo
United TherapeuticsUTHR
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's total costs & expenses?
AptarGroup (ATR) reported total costs & expenses of $875.37M in Q1 2026.
How has AptarGroup's total costs & expenses changed year-over-year?
AptarGroup's total costs & expenses increased by 13.1% year-over-year, from $773.86M to $875.37M.
What is the long-term trend for AptarGroup's total costs & expenses?
Over 4 years (2021 to 2025), AptarGroup's total costs & expenses has grown at a 3.3% compound annual growth rate (CAGR), from $2.88B to $3.28B.
What does total costs & expenses mean?
Total costs and expenses represent the sum of all operating and non-operating costs incurred by the company during a reporting period. This includes the cost of goods sold, operating expenses, and any other charges necessary to conduct business.